A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection

Clinical trial NCT06966284 · RECRUITING

Trial details

NCT number: NCT06966284
Sponsor: TTY Biopharm
Status: RECRUITING
Study type: OBSERVATIONAL

Bacteremia Caused by Gram-Negative Bacteria Bacterial Pneumonia

Start date: 2025-11-26
Primary completion: 2028-11-30
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.